Selected publications

Show all publications (PubMed) 

The biliary epithelium presents antigens to and activates natural killer T cells.
Schrumpf E, Tan C, Karlsen T, Sponheim J, Björkström N, Sundnes O, et al
Hepatology 2015 Oct;62(4):1249-59

High-resolution determination of human immune cell signatures from fine-needle liver aspirates.
Hengst J, Theorell J, Deterding K, Potthoff A, Dettmer A, Ljunggren H, et al
Eur. J. Immunol. 2015 Jul;45(7):2154-7

Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells.
Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson M, Kekäläinen E, et al
J. Immunol. 2015 Mar;194(6):2467-71

NK cell activation in human hantavirus infection explained by virus-induced IL-15/IL15Rα expression.
Braun M, Björkström N, Gupta S, Sundström K, Ahlm C, Klingström J, et al
PLoS Pathog. 2014 Nov;10(11):e1004521

In situ characterization of intrahepatic non-parenchymal cells in PSC reveals phenotypic patterns associated with disease severity.
Berglin L, Bergquist A, Johansson H, Glaumann H, Jorns C, Lunemann S, et al
PLoS ONE 2014 ;9(8):e105375

Effects of HDV infection and pegylated interferon α treatment on the natural killer cell compartment in chronically infected individuals.
Lunemann S, Malone D, Grabowski J, Port K, Béziat V, Bremer B, et al
Gut 2015 Mar;64(3):469-82

Differentiation and functional regulation of human fetal NK cells.
Ivarsson M, Loh L, Marquardt N, Kekäläinen E, Berglin L, Björkström N, et al
J. Clin. Invest. 2013 Sep;123(9):3889-901

Compromised function of natural killer cells in acute and chronic viral hepatitis.
Lunemann S, Malone D, Hengst J, Port K, Grabowski J, Deterding K, et al
J. Infect. Dis. 2014 May;209(9):1362-73

Tissue-specific effector functions of innate lymphoid cells.
Björkström N, Kekäläinen E, Mjösberg J
Immunology 2013 Aug;139(4):416-27

Hantavirus-infection confers resistance to cytotoxic lymphocyte-mediated apoptosis.
Gupta S, Braun M, Tischler N, Stoltz M, Sundström K, Björkström N, et al
PLoS Pathog. 2013 Mar;9(3):e1003272

CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells.
Björkström N, Béziat V, Cichocki F, Liu L, Levine J, Larsson S, et al
Blood 2012 Oct;120(17):3455-65

Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.
Stegmann K, Björkström N, Ciesek S, Lunemann S, Jaroszewicz J, Wiegand J, et al
J. Infect. Dis. 2012 May;205(9):1351-62

Longitudinal analysis of the human T cell response during acute hantavirus infection.
Lindgren T, Ahlm C, Mohamed N, Evander M, Ljunggren H, Björkström N
J. Virol. 2011 Oct;85(19):10252-60

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus.
Björkström N, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M, et al
J. Exp. Med. 2011 Jan;208(1):13-21

CD56 negative NK cells: origin, function, and role in chronic viral disease.
Björkström N, Ljunggren H, Sandberg J
Trends Immunol. 2010 Nov;31(11):401-6

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education.
Björkström N, Riese P, Heuts F, Andersson S, Fauriat C, Ivarsson M, et al
Blood 2010 Nov;116(19):3853-64

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
Stegmann K, Björkström N, Veber H, Ciesek S, Riese P, Wiegand J, et al
Gastroenterology 2010 May;138(5):1885-97

Analysis of the KIR repertoire in human NK cells by flow cytometry.
Björkström N, Fauriat C, Bryceson Y, Sandberg J, Ljunggren H, Malmberg K
Methods Mol. Biol. 2010 ;612():353-64

Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype.
Fauriat C, Andersson S, Björklund A, Carlsten M, Schaffer M, Björkström N, et al
J. Immunol. 2008 Nov;181(9):6010-9

Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection.
Björkström N, Gonzalez V, Malmberg K, Falconer K, Alaeus A, Nowak G, et al
J. Immunol. 2008 Sep;181(6):4219-28